“Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer” has been added to your cart. View cart
Article: PP04 Limitations of CLL-1 (CLEC12A) as a putative marker of leukemic stem cells in acute myeloid leukemia
PP04 Limitations of CLL-1 (CLEC12A) as a putative marker of leukemic stem cells in acute myeloid leukemia
Reviews
There are no reviews yet.
Be the first to review “Article: PP04 Limitations of CLL-1 (CLEC12A) as a putative marker of leukemic stem cells in acute myeloid leukemia” Cancel reply
Reviews
There are no reviews yet.